INTRODUCTION
Some 600 million people worldwide have high blood pressure and nearly 3 million die every year as a direct result. Yet seven out of every 10 people with hypertension are not being treated adequately, according to WHO and the International Society of Hypertension (ISH). Combination drug therapy is recommended for patients whose blood pressure does not fall to optimal levels with single-drug treatment.
Bilayer tablet is new era for successful development of controlled release formulation along with various features to provide successful drug delivery system. Bilayer tablet is suitable for sequential release of two drugs in combination, separate two incompatible substances and also for sustained release tablet in which one layer is immediate release as loading dose and second layer is maintenance dose. The immediate release layer of bilayer tablet has worked as the loading dose and the sustained release layer has maintained therapeutic plasma drug concentration for prolonged time.
It is envisaged that the proposed work is designed as the Bilayer tablet of hydrochlorothiazide and candesartan. One layer of the bilayer tablet contains the hydrochlorothiazide as instant release, and the remaining second layer contains the canedesartan as control Layer. Hydrochlorothiazide is a thiazide diuretic that helps prevent your body from absorbing too much salt, which can cause fluid retention. Candesartan is an angiotensin II receptor antagonists. Candesartan keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow.The combination of Hydrochlorothiazide and Candesartan is used to treat high blood pressure (hypertension). 
MATERIAL AND METHODS

Materials
Methods
Preformulation
Physiochemical Properties of candesartan and hydrochlorothiazide
A) Organoleptic evaluation
It refers to the evaluation by sensory characters-taste, appearance, odor, feel of the drug, etc.
B) Solubility (at room temp: )
We will check the solubility of both of drugs in water, hot water, 0.1N HCL, 0.1 NaOH, acetone, ethanol, chloroform, methanol at room temperature.
C) Identification Test
FTIR Spectroscopy
Infra-red spectrum is an important record which gives sufficient information about the structure of a compound. This technique provides a spectrum containing a large number of absorption band from which a wealth of information can be derived about the structure of an organic compound. 1gm of the Powder was taken and dissolved in 100ml of distilled water with sonication and filtered, pH of the filtrate was checked with standard glass electrode.
F) Melting point:
It is one of the parameters to judge the purity of drugs. In case of pure chemicals, melting points are very sharp and constant. Since the drugs contain the mixed chemicals, they are described with certain range of melting point. A small quantity of powder was placed into a fusion tube. That tube is placed in the melting point determining apparatus containing castor oil. The temperature of the castor oil was gradual increased automatically and read the temperature at which powder started to melt and the temperature when all the powder gets melted.
G) Bulk properties
A known quantity of powder was poured into the measuring cylinder carefully level the powder without compacting, if necessary and read the unsettled apparent volume, Vo, to the nearest graduated unit. Calculate the bulk density, in gm per ml gm/cc, by the formula Bulk density = Bulk Mass/ Bulk Volume H) Compressibility index (Carr's index) : Compressibility index (C.I.) is an important measure that can be obtained from the bulk and tapped densities. Carr's index a material having values of less than 20% to 30% is defined as the free flowing material. Shown in Table 1 .
It can be calculated as per given formula: 
I) Hausner ratio:
It indicates the flow properties of the powder and is measured by the ratio of tapped density to bulk density. Shown in Table 2 .
Hausner ratio = Tapped density / Bulk Density 
J) Angle of repose:
The angle of repose is a relatively simple technique for estimating the flowability of a powder through a funnel and fall freely onto a surface. The height and diameter of the resulting cone is measured and using the following equation, the angle of repose can be calculated.
Tan θ = h/r
Where h, r is the relatively height and radius of the powder cone.
For most pharmaceutical powders, the angle of repose values range form 25 to 45, with lower values indicating better flow characteristics. Values of angle of repose ≤ 30 usually indicate a free flowing material and angle ≥40 suggest a poorly flowing material.
k) MOISTURE CONTENT DETERMINATION
Principle: The titrimetric determination of water is based upon the quantitative reaction of water with an anhydrous solution of sulphur dioxide and iodine in the presence of a buffer that reacts with hydrogen ions. In the original titrimetric solution, known as Karl Fisher Reagents, the sulfur dioxide and iodine was dissolved in pyridine and methanol. The test specimen may be titrated with the reagent directly, or the analysis may be carried out by a residual titration procedure. The stoichiometry of the reaction is not exact, and the reproducibility of a determination depends upon such factors as the relative concentration of the reagent ingredients, the nature of the inert solvent used to dissolve the test specimen, and the technique used in the particular determination. Therefore, an empirically standardized technique is used in order to achieve the desired accuracy. Precision in the method is governed largely by the extent to which atmospheric moisture is excluded from the system. The titration of water is usually carried out with the use of anhydrous methanol as the solvent for the test specimen; however other suitable solvents may be used for special or unusual test specimens.
(Note: Now-a-days pyridine free KF reagents are coming in which pyridine is replaced by the imidazole, because pyridine has carcinogenic effects).
L) DETERMINATION OF λ max. OF CANDESARTAN
Accurately weighed 10 mg of drug was dissolved in 10 ml of 6.8 PH buffer solution in 10 ml of volumetric flask.the resulted solution 1000µg/ml and from this solution 1 ml pippet out and transfer into 10 ml volumetric flask and volume make up with 6.8 PH buffer solution prepare suitable dilution to make it to a concentration range of 5-25 μg/ml. The spectrum of this solution was run in 200-400 nm range in U.V spectrophotometer (Labindia-3000+).The Candesartan shows the absorbance maxima at 257 nm in 6.8 PH buffer solution.
M) DETERMINATION OF λ max. OF HYDROCHLOROTHIAZIDE
Accurately weighed 10 mg of drug was dissolved in 10 ml of 6.8 PH buffer solution (methanol used as cosolvent) in 10 ml of volumetric flask. The resulted solution 1000µg/ml and from this solution 1 ml pippet out and transfer into 10 ml volumetric flask and volume make up with 6.8 PH buffer solution prepare suitable dilution to make it to a concentration range of 5-25 μg/ml. The spectrum of this solution was run in 200-400 nm range in U.V spectrophotometer (Labindia-3000+). The
Hydrochlorothiazide shows the absorbance maxima at 272 nm in 6.8 PH buffer solutions.
PHASE-I PREPRATION OF INSTANT LAYER OF HYDROCHLOROTHIAZIDE
Fast dissolving tablets of Hydrochlorothiazide were prepared by direct compression method after incorporating different superdisintegrants such as, crosscarmellose sodium (Ac-Di-Sol), crospovidone and sodium starch glycolate in different concentrations. The above ingredients was weighed and mixed in geometric progression in a dry and clean mortar. Then the ingredients were passed through mesh #60.
Magnesium stearate as lubricant and talc as glidant were added in a final step and mixed, this blend was subjected to analysis of pre-compression parameters which included Angle of repose, Bulk density, Tap density, Carr's index and Hausner's ratio. 
EVALUATION OF POSTCOMPRESSION PARAMETER
Shape and colour of tablets:
Uncoated tablets were examined under a lens for the shape of the tablet and colour was observed by keeping the tablets in light.
 Thickness test
Three tablets were picked from each formulation randomly and thickness was measured individually. It is expressed in mm and standard deviation was also calculated. The tablet thickness was measured using dial-caliper (Mitutoyo, Japan).
 Weight variation test
Twenty tablets were selected randomly from each formulation and average weight was determined. The tablets were weighed individually and compared with average weight. The U.S Pharmacopoeia allows a little variation in the weight of a tablet. The following percentage deviation in weight variation is allowed (Table  No. 6.7). More than 130 mg and less than 324 mg 7.5 3.
324 mg or more 5
In all the formulations the tablets weight is more than 130 mg and less than 324 mg, hence 7.5% maximum difference allowed.
 Hardness test
The hardness of tablet was measured by Pfizer hardness tester and results were expressed in Kg/cm 2 .
 Friability test
For this, 20 tablets were taken from each formulation and the friability was determined using Roche friabilator. The equipment was run for 4min at 25 revolutions per minute. The tablets were taken out, dedusted and reweighted and % friability was calculated. The friability was determined as the mass loss in percent according to Equation:-
The test complies if tablets not lose more than 1% of their weight
 Uniformity of drug content:
The test is mandatory for tablets with 10 mg or less weight of active ingredient. Ten randomly selected tablets from each formulation (F1 to F9) were finely powdered and Drug equivalent to 10 mg of drug dissolved in 10 ml 0.1 N HCl (simulated gastric fluid of pH 1.2 without enzymes) sonicate it for 20 minutes, till the entire drug leached out from complex, then the solution was filtered through whatman filter paper No. 41. From this Solution take 1ml and Diluted up to 100 ml with 0.1 N HCl and the drug content was determined spectrophotometrically at 272.0 nm.
PREPRATION OF CANDESARTAN MATRIX TABLET
Direct compression was followed to manufacture the gas generating floating tablets of simvastatin. All the polymers selected, drug and excipients were passed through sieve no. 40 before using into formulation. Polymers selected for tablets are HPMC K15, HPMC K4, PVP-K30. Excipients like Lactose anhydrous,Talc, Magnesium Stearate were selected for the study.
Steps involved in the manufacture of tablets
First the drug, polymer and other excipients selected were passed through 40-mesh sieve. Required quantity of drug, polymer and excipients were weighed properly and transferred into polyethylene bag and the blend was mixed for at least 15 min.
The blend obtained was then lubricated by adding 1% magnesium stearate and again mixed for another 5min. 
EVALUATION OF MATRIX TABLET
All the tablets were evaluated for following different parameters which includes;
General Appearance
Five tablets from different batches were randomly selected and organoleptic properties such as color, odor, taste, shape, were evaluated. Appearance was judged visually.
Very good (+++), good (++), fair (+) poor (-), very poor (--).
Thickness and diameter
Thickness and diameter of tablets were determined using Vernier caliper. Five tablets from each batch were used, and an average value was calculated.
Hardness
For each formulation, the hardness of five tablets was determined using the Monsanto hardness tester (Cadmach).
Friability
The friability of a sample of 10 tablets was measured using a Friability tester (Electro Lab). Ten tablets were weighed, rotated at 25 rpm for 4 minutes. Tablets were reweighed after removal of fines (dedusted) and the percentage of weight loss was calculated.
Uniformity of weight
Twenty tablets were randomly selected from each batch individually weighed, the average weight and standard deviation of 20 tablets was calculated.
Drug content
Twenty tablets were taken and amount of drug present in each tablet was determined. The tablets were crushed in a mortar and the powder equivalent to 100 mg of drug was transferred to 100ml standard flask. The powder was dissolved in 50 ml of pH 6.8 Phosphate Buffer and made up to volume with buffer. The sample was mixed thoroughly and filtered through a 0.45μ membrane filter. The filtered solution was diluted suitably and analyzed for drug content by UV spectrophotometer at a λmax of 257.0 nm using of pH 6.8 Phosphate Buffer as blank.
 Dissolution rate studies
In vitro drug release of the sample was carried out using USP-type II dissolution apparatus (Paddle type). The dissolution medium, 900 ml pH 6.8 Phosphate Buffer (Tween 20, 0.1%) was placed into the dissolution flask maintaining the temperature of 37±0.50c and rpm of 50. One Candesartan Control layer tablet was placed in each basket of dissolution apparatus. The apparatus was allowed to run for 12 hours. Sample measuring 4 ml were withdrawn after 30 min., 1.0 hr, 1.30 hr, 2.0 hr, 3hr., 4.0 hr, 6.0 hr, 8.0hr 10.0 hr, 12 hour using 4 ml pipette. The fresh dissolution medium was replaced every time with the same quantity of the sample.
FORMULATION OF BILAYER TABLETS
Optmized bach of Instant Layer (TM4) and Optmized bach of Sustain layer(F7) used to formulate Bilayer tablet of Hydrochlorothiazide and Candesartan. Procedure of formulation same as method as previous.
General Appearance
Thickness and diameter
Hardness
Friability
Uniformity of weight
Drug content
Twenty tablets were taken and amount of drug present in each tablet was determined. The tablets were crushed in a mortar and the powder equivalent to 32 mg of Candesartan was transferred to 100ml standard flask. The powder was dissolved in 50 ml of methanol and made up to volume with methanol. The sample was mixed thoroughly and filtered through a 0.45μ membrane filter. The filtered solution was further diluted 1 ml to 10ml suitably (32 ppm of candesartan and 25 ppm of Hydrochlorothiazide) and Determine the Conc. of both drugs using Simultaneous estimation method
Dissolution rate studies
In vitro drug release was performed according to the USP dissolution apparatus II at 50 rpm and 37±0.5ºC temperature over a 12 hrs period for Candesartan SR and 2 hr for Hydrochlorothiazide IR, using an automated paddle dissolution system (Labindia). A minimum of 6 tablets per batch were tested.
The media used was 0.1N HCl at a pH 1.2 and a volume of 900 ml for the first 2 hours after and then pH of 6.8 and maintained at 37+ 0.5•C upto 12 Hours. Test sample (4ml) was withdrawn at particular time interval and replaced with fresh dissolution media maintained at the same temperature and the concentration of dissolved drug was determined using U.V. (Ultraviolet Labindia 3000+) spectrophotometer at λmax 257 nm for Candesartan and 272.0 nm for Hydrochlorothiazide.
RESULTS AND OBSERVATION
PREFORMULATION
PHYSICO-CHEMICAL PROPERTIES OF CANDESARTAN AND HYDRO -CHLOROTHIAZIDE
A). Organoleptic evaluation: 
Sample of pure Candesartan and Hydrochlorothiazide
The IR spectrum of sample drug shows the peak values which are characteristics of the drug and the graph was shown in figure no. 7.1 and 7.2. 
E) Loss on Drying (LOD):
Procedure: Loss on drying directly measuring by IR moisture balance. Firstly calibrate the instrument by knob then take 1.000 gm sample (powder) and set the temp at 100°C to 105°C for 5 minutes and constant reading set the knob and check % moisture.
Result:
The percentage of loss on drying of Candesartan and hydrochlorothiazide 0.020 %w/w and 0.0255 %w/w.
F) Determination of pH (1 w/v solution in water):
The pH determination of Candesartan and Hydrochlorothiazide was done by Digital pH meter and found to be 6.4 and.4.43.
G) Melting Point:
Procedure: A small quantity of powder was placed into a fusion tube. That tube is placed in the melting point determining apparatus containing castor oil.
The temperature of the castor oil was gradually increased automatically and read the temperature at which powder started to melt and the temperature noted when all the powder gets melted. A known quantity of powder was poured into the measuring cylinder carefully level the powder with out compacting, if necessary and read the unsettled apparent volume, V o , to the nearest graduated unit. Calculate the bulk density, in gm/ml gm/cc, by the formula. 
Result
Bulk density = Bulk Mass/ Bulk Volume
OR
Result:
The compressibility index of Candesartan and hydrochlorothiazide respectively is 45% and 44.2%.
 Hausner ration:
Hausner Ratio = Tapped density / Bulk Density
Result:
The Hausner ration of candisaratn and hydrochlorothiazide respectively is 1.818 and 1.77.
 Angle of Repose
Procedure: The angle of repose is a relatively simple technique for estimating the flowability of a powder through a funnel and fall freely onto a surface. The height and diameter of the resulting cone is measured and using the following equation, the angle of repose can be calculated. Weigh 10 gm of drug (Candesartan and Hydrochlorothiazide) powder accurately, and pass through the fennel height up to2.5 cm from surface and measure the height and diameter by scale.
Tan θ = h/r
Result:
The Angle of repose of Candesartan and hydrochlorothiazide 38.0& 37.0 degree respectively.
Partical size pass through 40# is 100 (%w/w).
I) Moisture by Karl-Fischer Apparatus (KF)
Result: The Moisture content of Candesartan and hydrochlorothiazide is 0.1095 and 0.073% respectively.
DETERMINATION OF λ MAX BY UV-VISIBLE SPECTROSCOPY
Standard solution (10g/ml) of pure Candesartan and Hydrochlorothiazide was prepared. The pure drug solutions were scanned on UV spectrophotometer, which showed maximum absorbance at 257.0nm and 272.0nm for Candesartan and hydrochlorothiazide respectively. 
Prepration of Calibration Curve of Candesartan
Accurately weighed 10 mg of pure Candesartan was dissolved in 2.0 ml of methanol and volume make upto 10 ml with 6.8 pH buffer solution in 10 ml of volumetric flask and prepare suitable dilution to make it to a concentration of 1000μg/ml make adequate of sample with concentration range of 5-25 μg/ml with with 6.8 pH buffer solution. The spectrum of this solution was run in 200-400 nm range in U.V spectrophotometer. 
COMPATIBILITY STUDIES OF DRUG AND EXCIPIENTS
In the compatibility testing program, blends of drug and excipients are prepared by triturating the drug with Individual excipients.
Procedure: Take 50 mg accurately weigh of drug dry powder and 50 mg of excipients and mix the blend of drug and excipients and binary/tertiary blends of extract and excipients were prepared and transferred to inert glass vials. The mouths of the vials were covered with rubber closures followed by the aluminum seal caps. Binary/tertiary blends of extract and excipients, drug neat and excipients were stored at 4˚C (refrigerator) as control; and at 40˚C/75%RH for accelerated stability studies for 4 weeks. The visual observations (color, flow, & sticking) were recorded for initial and at the end of the first, second, third and fourth week.
PHASE I-PREPRATION OF INSTANT LAYER OF HYDROCHLOROTHIAZIDE
Evaluation of Pre-compression Parameters:
Blend ready for compression containing drug and various excipients was subjected for pre-compression parameters to study the flow properties of granules, to achieve uniformity of tablet weight.
A) Angle of repose (θ):
The data obtained for angle of repose for all the formulations were tabulated in Table No .7.8. The values were found to be in the range of 34 o ' to41 o . All the formulations prepared showed the angle of repose less than 41°, which reveals passable flow property.
B) Loose Bulk Density and Tapped Bulk Density:
Loose bulk density (LBD) and tapped bulk density (TBD) for the blend is shown in Table No .7.8 The loose bulk density and tapped bulk density for all the formulation blend varied from 0.33 gm/cm 3 to 0.34 gm/cm 3 and 0.50 gm/cm 3 to 0.53 gm/cm 3 respectively.
C) Carr's compressibility index and Hausner's ratio:
The results of Carr's consolidation index or compressibility index (%) for the entire formulation blend ranged from 28.30 to 40.38. The directly compressible granulations had shown excellent compressibility index values which results in Poor flow properties.
The results of Hausner's ratio for all the formulation blend is less than 0.570, which shows good flow property. 
Evaluation of Post-compression parameters A) Shape and colour of tablets:
Formulations prepared were randomly picked from each batch examined under lens for shape and in presence of light for colour. Tablets showed flat, circular shape in pinkish colour due to add of Colouring agent.
B) Thickness test
Thickness of the tablets was measured by dial caliper by picking randomly from all the batches. The results of thickness for tablets were shown in Table No . The mean thickness was (n=3) almost uniform in all the formulations and values ranged from 1.40 ± 0.10 mm. The standard deviation values indicated that all the formulations were within the range.
C) Weight variation test
The weight variation test is done to ensure the tablet contains the proper amount of drug. All the tablets passed weight variation test as the average percentage weight variation was within the pharmacopoeial limits of ±10% (Table7.9).
D) Hardness test
The hardness of all the tablets prepared was maintained within the 2.00 kg/cm 2 to 4.00 kg/cm 2 . All the tablets maintained hardness in the range 2.51 ± 0.71 kg/cm 2 to 3.59 ± 0.51 kg/cm 2 for formulations were almost uniform.
E) Friability test
The study results tabulated in Table no.7.9 was found to be well within the approved range (<1%) in all designed formulations. The formulations TM-1 and TM-8 showed slightly higher than the other. This might be due to excess fines or due to improper granulation, but the values were found to be within the limit. Thus tablets possess good mechanical strength.
F) Uniformity of drug content:
The content uniformity was performed for all the nine formulations and results are tabulated in Table No.7.9 Three trials from each batch were analyzed spectrophotometrically. The average value and standard deviations of all the formulations were calculated. The drug content in different formulation was highly uniform and in the range of 98.51±0.75-99.53±0.42 %.The results were within the acceptable range and that indicated uniformity of mixing. The cumulative percentage drug released by each tablet in the in vitro release studies was based on the average drug content present in the tablet.
G) In-vitro disintegration time:
It was observed that the disintegration time of tablets decreased with increase in the concentration of the superdisintegrants. Based on the disintegration results (Table 7 .10), the formulation containing crosspovidone (7.5%) showed the fastest disintegration.
Among the different formulations, TM4 was chosen as optimized batch containing croscarmilose sodium (5%) as superdisintegrant, as it has produced the ODT having least disintegration time of 12.0 ± 0.21 sec. 
RESULTS OF POST COMPRESSION PROPERTIES OF BILAYER TABLETS
Figure 24: release of Candesartan
In the present study seven formulations with variable conc entration of polymers (HPMC K-4 and K-15) prepared by direct compression method and evaluated for physiochemical properties, buoyancy lag time ad invitro drug release.
The results indicated that optimized the gastric fluid, formulation F7 of matrix tablet and TM4 formulation of instant release on immersion in 0.1N HCl solution for 2 hour and then at pH 6.8 phosphate buffer at 37±0.5 0 C tablets immediately and remain buoyant upto 12hrs without disintegration.
These two factors are essential for the tablet to acquire bul k density < 1, so that it remains buoyant on The In vitro drug release data of the optimized formulation was subjected to goodness of fit test by linear regression analysis according to zero order, first order kinetic equation, Higuchi's and Korsmeyer's models in order to determine the mechanism of drug release. When the regression coefficient values of were compared, it was observed that 'r' values of first order was maximum i.e 0.999 hence indicating drug release from formulations was found to follow Korsmeyer's models.
CONCLUSION
Bilayer tablet is improved beneficial technology to overcome the shortcoming of the single layered tablet. There is various application of the bi-layer tablet it consist of monolithic partially coated or multilayered matrices. Bilayer tablet is suitable for sequential release of two drugs in combination, separate two incompatible substances and also for sustained release tablet in which one layer is immediate release as initial dose and second layer is maintenance dose. The preparation of tablets in the form of multi layers is used to provide systems for the administration of drugs, which are incompatible and to provide controlled release tablet preparations by providing surrounding or multiple swelling layers. Bilayer tablet quality and GMP-requirements can vary widely. Bilayer tablets offer an excellent opportunity for manufacturers to separate themselves from their competitors, improve their products' efficacy, and protect against impersonator products.
